TY - JOUR
T1 - Prospective longitudinal changes in the periodontal inflamed surface area following active periodontal treatment for chronic periodontitis
AU - Nomura, Yoshiaki
AU - Morozumi, Toshiya
AU - Saito, Atsushi
AU - Yoshimura, Atsutoshi
AU - Kakuta, Erika
AU - Suzuki, Fumihiko
AU - Nishimura, Fusanori
AU - Takai, Hideki
AU - Kobayashi, Hiroaki
AU - Noguchi, Kazuyuki
AU - Takahashi, Keiso
AU - Tabeta, Koichi
AU - Umeda, Makoto
AU - Minabe, Masato
AU - Fukuda, Mitsuo
AU - Sugano, Naoyuki
AU - Hanada, Nobuhiro
AU - Yoshinari, Nobuo
AU - Sekino, Satoshi
AU - Takashiba, Shogo
AU - Sato, Soh
AU - Nakamura, Toshiaki
AU - Sugaya, Tsutomu
AU - Nakayama, Yohei
AU - Ogata, Yorimasa
AU - Numabe, Yukihiro
AU - Nakagawa, Taneaki
N1 - Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/3/2
Y1 - 2021/3/2
N2 - Periodontal disease is a chronic inflammatory disease of the periodontal tissue. The periodontal inflamed surface area (PISA) is a proposed index for quantifying the inflammatory burden resulting from periodontitis lesions. This study aimed to investigate longitudinal changes in the periodontal status as evaluated by the PISA following the active periodontal treatment. To elucidate the prognostic factors of PISA, mixed-effect modeling was performed for clinical parameters, tooth-type, and levels of periodontal pathogens as independent variables. One-hundred-twenty-five patients with chronic periodontitis who completed the active periodontal treatment were followed-up for 24 months, with evaluations conducted at 6-month intervals. Five-times repeated measures of mean PISA values were 130+/−173, 161+/−276, 184+/−320, 175+/−417, and 209+/−469 mm2. Changes in clinical parameters and salivary and subgingival periodontal pathogens were analyzed by mixed-effect modeling. Plaque index, clinical attachment level, and salivary levels of Porphyromonas gingi-valis were associated with changes in PISA at the patient-and tooth-level. Subgingival levels of P. gingivalis and Prevotella intermedia were associated with changes in PISA at the sample site. For most patients, changes in PISA were within 10% of baseline during the 24-month follow-up. However, an increase in the number of bleeding sites in a tooth with a deep periodontal pocket increased the PISA value exponentially.
AB - Periodontal disease is a chronic inflammatory disease of the periodontal tissue. The periodontal inflamed surface area (PISA) is a proposed index for quantifying the inflammatory burden resulting from periodontitis lesions. This study aimed to investigate longitudinal changes in the periodontal status as evaluated by the PISA following the active periodontal treatment. To elucidate the prognostic factors of PISA, mixed-effect modeling was performed for clinical parameters, tooth-type, and levels of periodontal pathogens as independent variables. One-hundred-twenty-five patients with chronic periodontitis who completed the active periodontal treatment were followed-up for 24 months, with evaluations conducted at 6-month intervals. Five-times repeated measures of mean PISA values were 130+/−173, 161+/−276, 184+/−320, 175+/−417, and 209+/−469 mm2. Changes in clinical parameters and salivary and subgingival periodontal pathogens were analyzed by mixed-effect modeling. Plaque index, clinical attachment level, and salivary levels of Porphyromonas gingi-valis were associated with changes in PISA at the patient-and tooth-level. Subgingival levels of P. gingivalis and Prevotella intermedia were associated with changes in PISA at the sample site. For most patients, changes in PISA were within 10% of baseline during the 24-month follow-up. However, an increase in the number of bleeding sites in a tooth with a deep periodontal pocket increased the PISA value exponentially.
KW - Follow-up study
KW - Mixed effect modeling
KW - Periodontal inflamed surface area
KW - Periodontal pathogen
UR - http://www.scopus.com/inward/record.url?scp=85111115422&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85111115422&partnerID=8YFLogxK
U2 - 10.3390/jcm10061165
DO - 10.3390/jcm10061165
M3 - Article
AN - SCOPUS:85111115422
SN - 2077-0383
VL - 10
SP - 1
EP - 14
JO - Journal of Clinical Medicine
JF - Journal of Clinical Medicine
IS - 6
M1 - 1165
ER -